Plasmid Biopharmaceuticals
Basics, Applications, and Manufacturing
1. Edition August 2011
616 Pages, Hardcover
Wiley & Sons Ltd
Short Description
A plasmid is a DNA molecule separate from chromosomal DNA and capable of autonomous replication. Plasmid Biopharmaceuticals helps pharmaceutical scientists and engineers understand the basic characteristics of therapeutic DNA plasmids, their potential utilization in drug development, and the issues and solutions for large-scale GMP production. Bringing together information on plasmid basics and applications, the book also addresses a range of manufacturing-related issues. It is an essential guide for academic and industrial researchers concerned with plasmid DNA manufacturing for pharmaceutical applications.
The book addresses the basics, applications, and manufacturing of plasmid biopharmaceuticals. The survey of the most relevant characteristics of plasmids provides the basics for designing plasmid products (applications) and processes (manufacturing). Key features that the authors include in the book are: i) consistency and clear line of direction, ii) an extensive use of cross-referencing between the individual chapters, iii) a rational integration of chapters, iv) appellative figures, tables and schemes, and v) an updated, but selected choice of references, with a focus on key papers.
Acknowledgment.
Abbreviations.
Part I Basics.
1 Historical Perspective.
2 Gene Transfer with Plasmid Biopharmaceuticals.
3 Product and Process Development.
4 Structure.
5 Analytical Characterization.
6 Delivery.
Part II Applications.
7 Ethical and Safety Issues.
8 Human and Veterinary Markets.
9 Human Case Studies: Pandemic Infl uenza and Critical Limb Ischemia.
10 Veterinary Case Studies: West Nile, Infectious Hematopoietic Necrosis, and Melanoma.
Part III Manufacturing.
11 Good Manufacturing Practice and Validation.
12 Product Specifi cations and Quality Control.
13 Cell Culture.
14 An Overview of Downstream Processing.
15 Primary Isolation.
16 Intermediate Recovery.
17 Final Purifi cation.
18 Process Synthesis.
Part IV Concluding Remarks and Outlook.
19 Concluding Remarks and Outlook.
Index.
